9Kinoshita A,Saito T,Tomita H,et al. Domain - specific mutations inTGFB1 result in Camurati - Engelmann disease [ J ] . Nat Genet,2000,l:19-20.
10Janssens K,Dijke P,Ralston SH,et al. Transforming growth factor -beta 1 mutations in Camurati — Engelmann disease lead to increasedsignaling by altering either activation or secretion of the mutant pro-tein[J]. J Biol Chem ,2003 ,9:7718 -7724.
二级参考文献7
1Bernardo ME, Emons JA, Karperien M, et al. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources [ J ]. Connect Tissue Res, 2007,3 : 132 - 140.
2Yoshimura H, Muneta T, Nimura A, et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle [ J]. Cell Tissue Res,2007 ,3 :449 -462.
3Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: cell biology and potential use in therapy [ J ]. Basic Clin Pharmacol Toxico1,2004,5:209 - 214.
4Li WJ , Tuli RC, Okafor CK, et al. A three - dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells [ J ] . Biomaterials,2005,6 : 599 - 609.
5Barry F, Boynton RE, Liu B ,et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow:differentiation dependent gene expression of matrix components [ J ]. Exp Cell Res, 2001,2 : 189 - 200.
6Fukumoto T, Sperling JW, Sanyal A, et al. Combined effects of insulin - like growth factor - Ⅰ and transforming growth factor - beta1 on periosteal mesenchymal ceils during chondrogenesis in vitro [ J ]. Osteoarthritis Cartilage ,2003,1:55 - 64.
